Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation Expense (2016 - 2019)

Xtant Medical Holdings (XTNT) has disclosed Depreciation Expense for 10 consecutive years, with $800000.0 as the latest value for Q3 2019.

  • Quarterly Depreciation Expense changed 0.0% to $800000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Sep 2019, up 34.78% year-over-year, with the annual reading at $3.2 million for FY2018, 15.79% down from the prior year.
  • Depreciation Expense for Q3 2019 was $800000.0 at Xtant Medical Holdings, up from $700000.0 in the prior quarter.
  • The five-year high for Depreciation Expense was $2.0 million in Q3 2017, with the low at -$100000.0 in Q4 2017.
  • Average Depreciation Expense over 5 years is $653061.0, with a median of $747850.0 recorded in 2016.
  • The sharpest move saw Depreciation Expense tumbled 139.99% in 2017, then surged 900.0% in 2018.
  • Over 5 years, Depreciation Expense stood at $112750.0 in 2015, then skyrocketed by 121.8% to $250078.0 in 2016, then crashed by 139.99% to -$100000.0 in 2017, then soared by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • According to Business Quant data, Depreciation Expense over the past three periods came in at $800000.0, $700000.0, and $800000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.